AstraZeneca Shares Drop Following Report of a COVID-19 Vaccine Study Patient Death in Brazil

AstraZeneca Shares Drop Following Report of a COVID-19 Vaccine Study Patient Death in Brazil

Source: 
BioSpace
snippet: 

Shares of AstraZeneca dropped slightly Wednesday afternoon following reports that a patient participating in the Brazilian arm of the company’s global Phase III study has died.